Mastermind Session: Clarifying the Definition of Real World Evidence Across Different Sized Companies

Time: 11:45 am
day: Day One


This session offers you the opportunity to uncover the differences and similarities of the use of the term real world evidence in your internal-facing role. You will spend 20 minutes soundboarding these ideas and challenges that arise with your peers and spend that last 15 minutes of the session feeding back the points discussed and recommendations for next steps to mitigate any challenges you face or best practices you’ve uncovered.

• Exploring how various biopharma companies define and perceive real world evidence, highlighting commonalities and differences

• Discussing ongoing efforts and industry initiatives aimed at establishing a standardized framework for real world evidence across biopharma organizations

• Assessing next steps that need to be taken